ICD-10 Coding for Aplastic Anemia(D61.0, D61.0A, D61.0N)
Comprehensive guide to ICD-10 coding for aplastic anemia, including specific codes for drug-induced and chemotherapy-induced cases.
Complete code families applicable to Aplastic Anemia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D61.0 | Aplastic anemia due to drugs | Use when aplastic anemia is confirmed to be caused by specific drugs or chemicals. |
|
| D61.1 | Aplastic anemia due to radiotherapy/chemotherapy | Use when aplastic anemia is confirmed to be caused by chemotherapy or radiotherapy. |
|
| D61.9 | Unspecified aplastic anemia | Use when the cause of aplastic anemia is not specified in the documentation. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAplastic Anemia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Aplastic Anemia.
Failing to document the cause of aplastic anemia.
Impact
Clinical: Leads to incorrect treatment plans., Regulatory: Non-compliance with coding standards., Financial: Potential for reduced reimbursement.
Mitigation
Always document the cause if known., Use specific codes when the cause is identified.
Using D61.9 when a specific cause is documented.
Impact
Reimbursement: May result in lower reimbursement due to lack of specificity., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.
Mitigation
Ensure the cause of aplastic anemia is clearly documented and use the specific code.
Specificity of coding
Impact
Using unspecified codes when specific causes are documented.
Mitigation
Ensure thorough documentation of the cause of anemia.